Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Gains from Sales and Divestitures (2017 - 2019)

CV Sciences' Gains from Sales and Divestitures history spans 2 years, with the latest figure at $2.9 million for Q4 2019.

  • For Q4 2019, Gains from Sales and Divestitures changed N/A year-over-year to $2.9 million; the TTM value through Dec 2019 reached $2.9 million, changed N/A, while the annual FY2019 figure was $2.9 million, N/A changed from the prior year.
  • Gains from Sales and Divestitures for Q4 2019 was $2.9 million at CV Sciences, up from $2.0 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $2.9 million in Q4 2019 and bottomed at $1.0 million in Q1 2017.